Cargando…
LncRNAs as the Regulators of Brain Function and Therapeutic Targets for Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common type of dementia and a serious threat to the health and safety of the elderly population. It has become an emerging public health problem and a major economic and social burden. However, there is currently no effective treatment for AD. Although the mechan...
Autores principales: | Liu, Yuqing, Chen, Xin, Che, Yutong, Li, Hongli, Zhang, Zheyu, Peng, Weijun, Yang, Jingjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116922/ https://www.ncbi.nlm.nih.gov/pubmed/35656102 http://dx.doi.org/10.14336/AD.2021.1119 |
Ejemplares similares
-
Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer’s Disease
por: Liu, Yuqing, et al.
Publicado: (2022) -
LncRNAs as Potential Therapeutic Targets in Thyroid Cancer
por: Javed, Zeeshan, et al.
Publicado: (2020) -
Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
por: Ye, Wen-Chu, et al.
Publicado: (2021) -
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
por: Li, Sui, et al.
Publicado: (2022) -
Insights into lncRNAs in Alzheimer’s disease mechanisms
por: Li, Dingfeng, et al.
Publicado: (2020)